Design
An observational cohort study was performed between 2015 and 2022. All
patients intended to undergo RAL surgery for any stage of endometrial
cancer as part of routine care at the Royal Marsden Hospital or any
other hospital of the Southwest Thames Gynaecological Cancer Centre we
operated in due to capacity constraints were included. All surgeries
were performed by three robot-trained gynaecological oncology surgeons.
Three generations of Da Vinci robots were used (S, Si, Xi).
Inclusion criteria were women diagnosed with endometrial cancer and the
intention of performing RAL hysterectomy, bilateral
salpingo-oophorectomy and/or any lymph node dissection. Patients with
non-endometrial primary histology or any additional cancer were excluded
from analysis.